Critical role for IL-13 in the development of allergen-induced airway hyperreactivity

Journal of Immunology

Volumn 167, Issue 8, 2001, Pages 4668-4675

  Walter, D M ^a   McIntire, J J ^a   Berry, G ^a   McKenzie, A N J ^a   Donaldson, D D ^a   Dekruyff, R H ^a   Umetsu, D T ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIASTHMATIC AGENT; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR BLOCKING AGENT; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; RECOMBINANT INTERLEUKIN 13; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHILIA; IMMUNOPATHOGENESIS; INFLAMMATORY DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; TH2 CELL; TRANSGENIC MOUSE;

EID: 0035888013     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.8.4668     Document Type: Article

References (49)

1. Evidence for the increase in asthma worldwide
2. The problem of atopic eczema: Aetiological clues from the environment and lifestyles
3. National survey of prevalence of asthma among children in the United States, 1976 to 1980
4. Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness
5. Interleukin (IL)-5 but not immunoglobulin E reconstitutes airway inflammation and airway hyperresponsiveness in IL-4-deficient mice
6. Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness
7. Interleukin-13: Central mediator of allergic asthma
8. Requirement for IL-13 independently of IL-4 in experimental asthma
9. Integrated signals between IL-13, L-4, and IL-5 regulate airways hyperreactivity
10. Impaired development of Th2 cells in IL-13-deficient mice
11. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses
12. An OVA-IL-12 fusion protein is more effective than OVA plus rIL-12 in inducing a Th I-dominated immune response and inhibiting antigen-specific IgE production
13. Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: Characterization and use as probes for the biology of the tumor in vivo and in vitro
14. Allergen-specific Thl cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation
15. Respiratory infection with influenza A virus interferes with the induction of tolerance to aeroallergens
16. + T cells to produce IL-4
17. + T cells and IL-18
18. Mechanisms preventing allergen-induced airways hyperreactivity: Role of tolerance and immune deviation
19. IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent
20. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5
21. Th2-induced airway mucus production is dependent on IL-4Ra, but not on eosinophils
22. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy
23. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma
24. Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects
25. Genetic variants of IL-13 signalling and human asthma and atopy
26. Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy
27. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children
28. An IL-13 promoter polymorphism associated with increased risk of allergic asthma
29. Atopy and asthma: Genetic variants of IL-4 and IL-13 signalling
30. Variation in the interleukin 4-receptor α gene confers susceptibility to asthma and atopy in ethnically diverse populations
31. IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells
32. Interleukin-13 modulates carbachol- and KCI-evoked contractile responses in murine tracheal rings
33. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
34. IL-13 over-expression predisposes to anaphylaxis following antigen sensitization
35. Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13
36. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway
37. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response
38. Temporal association between airway hyperresponsiveness and airway eosinophilia in ovalbumin-sensitized mice
39. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
40. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins
41. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
42. The importance of leukotrienes in airway inflammation in a mouse model of asthma
43. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
44. Induction of airway mucus production By T helper 2 (Th2) cells: A critical role for interleukin 4 in cell recruitment but not mucus production
45. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5
46. Eosinophils are not required to induce airway hyperresponsiveness after nematode infection
47. Inhibition of antigen-induced airway hyperresponsiveness, but not acute hypoxia nor airway eosinophilia, by an antagonist of platelet-activating factor
48. T-lymphocytes regulate genetically determined airway hyperresponsiveness in race
49. Anti-CD86 (B7.2) treatment abolishes allergic airway hyperresponsiveness in mice